“❣831 선릉2차룸 O1O=6454=7467 유미대표 청담동2차룸 매직미러초이스 정보 [가격,시스템,서비스,위치,노는법] 정보❣”的搜索结果，显示 231-240 项，共有 12878 项

1. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 study in a selected cohort of patient with LM. Prehabilitation. Rochester, Minn. Physical activity plays an important role in reducing the adverse effects ...

2. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Rochester, Minn. The primary objectives of this study are to determine the maximum tolerated dose/recommended phase 2 dose (MTD/RP2D) of selumetinib + ...

3. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   We postulate that our innovative approach will establish much needed immune microenvironment information and facilitate the identification of specific ...

4. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ability ...

5. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...

6. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   The purpose of this study is to evaluate the safety and feasibility of surgical resection for pre-recurrent brain tumors. Eligible patients with surgically ...

7. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor ...

8. 肺癌计划- 临床试验- 妙佑医疗国际

   The purpose of this study is to determine the maximum tolerated dose (MTD) and/or the recommended Phase 2 dose (RP2D) of WSD0922-FU in subjects with recurrent ...

9. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

   ... 2 drugs for the initial WT) and regimen ICE/Cyclo/Topo has on patients with high and very high risk relapsed FHWT (those treated with 3 or more drugs for ...

10. 肿瘤科（内科） - 临床试验- 妙佑医疗国际

    Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the body's immune system attack the cancer and may interfere with the ability ...